Using Convergent Mixed Methods To Evaluate Treatment Risks and Benefits In Rare Disease- An Example From A Phase Ii Registration Trial In Metastatic Merkel Cell Carcinoma
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1991
https://www.valueinhealthjournal.com/article/S1098-3015(17)32325-2/fulltext
Title :
Using Convergent Mixed Methods To Evaluate Treatment Risks and Benefits In Rare Disease- An Example From A Phase Ii Registration Trial In Metastatic Merkel Cell Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32325-2&doi=10.1016/j.jval.2017.08.1991
First page :
A731
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
1820